[1]
“THE IMPACT OF PHARMACEUTICAL CARE ON TREATMENT ADHERENCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, editora, p. 49–57, jul. 2025, doi: 10.63330/aurumpub.009-004.